BackJohnson Chemical Pharmaceutical Works , Ltd. Overview
Johnson Chemical Pharmaceutical Works Co., Ltd.

Johnson Chemical Pharmaceutical Works , Ltd. Return on Equity

Latest ROE for Johnson Chemical Pharmaceutical Works , Ltd.: 5.14% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

ROE

5.14%

Return on Equity

5.14%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Johnson Chemical Pharmaceutical Works , Ltd. (4747.TWO) FAQ

As of the most recent data, 4747.TWO shows a ROE of 5.14%. That is below the sector sector average of 11.75%. Scroll down for historical charts and peer comparison views.

The its sector sector average ROE is about 11.75%. Johnson Chemical Pharmaceutical Works , Ltd. is at 5.14%, which is lower that average. That is roughly 56.3% below the sector mean. Use the comparison chart on this page to see how 4747.TWO stacks up against individual peers as well.

Check the historical chart to see whether 4747.TWO's ROE is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Johnson Chemical Pharmaceutical Works , Ltd. with peers to see if the move is company-specific or sector-wide.

Besides this return on equity page, Stockcircle has Johnson Chemical Pharmaceutical Works , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect ROE (currently 5.14%) with ownership activity and broader fundamentals.